Nonhematologic adverse events suspected to be related to nilotinib
Adverse event (N=119 patients) . | All grades, %* . | Grade 3/4, % . |
---|---|---|
Rash | 22 | 0 |
Pruritus | 20 | 0 |
Constipation | 11 | 0 |
Headache | 10 | 1 |
Fatigue | 10 | 1 |
Nausea | 10 | 1 |
Diarrhea | 9 | 1 |
Muscle spasms | 9 | 0 |
Myalgia | 9 | 1 |
Alopecia | 8 | 0 |
Pyrexia | 8 | 1 |
Abdominal pain | 7 | 1 |
Anorexia | 6 | 0 |
Arthralgia | 5 | 0 |
Peripheral edema | 5 | 0 |
Upper abdominal pain | 5 | 0 |
Pain in extremity | 5 | 0 |
Adverse event (N=119 patients) . | All grades, %* . | Grade 3/4, % . |
---|---|---|
Rash | 22 | 0 |
Pruritus | 20 | 0 |
Constipation | 11 | 0 |
Headache | 10 | 1 |
Fatigue | 10 | 1 |
Nausea | 10 | 1 |
Diarrhea | 9 | 1 |
Muscle spasms | 9 | 0 |
Myalgia | 9 | 1 |
Alopecia | 8 | 0 |
Pyrexia | 8 | 1 |
Abdominal pain | 7 | 1 |
Anorexia | 6 | 0 |
Arthralgia | 5 | 0 |
Peripheral edema | 5 | 0 |
Upper abdominal pain | 5 | 0 |
Pain in extremity | 5 | 0 |
All grades are reported where the frequency was greater than 5%.